The Business Research Company’s Predictive Biomarkers Market Research Explores Growth Within A $25.64 Billion Opportunity
LONDON, GREATER LONDON, UNITED KINGDOM, August 25, 2026 /EINPresswire.com/ — “The predictive biomarkers market is gaining significant traction as advancements in healthcare and biotechnology unfold. With growing research and the rising prevalence of diseases such as cancer, this sector is poised for steady expansion in the coming years. Let’s explore the current market size, key growth drivers, regional insights, and future trends shaping this important field.
Steady Market Growth Projections for the Predictive Biomarkers Market
The predictive biomarkers market has demonstrated consistent growth recently and is expected to continue on this trajectory. Its value will rise from $20.96 billion in 2025 to $21.88 billion in 2026, reflecting a compound annual growth rate (CAGR) of 4.4%. This progress over the past years can be attributed to several factors including advancements in genomic research, increased adoption of targeted therapies, the growing number of cancer cases worldwide, expansion in molecular diagnostic tools, and supportive regulatory frameworks encouraging biomarker development.
Download a free sample of the predictive biomarkers market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20595&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR
Looking ahead, the market is forecasted to reach $25.65 billion by 2030, growing at a CAGR of 4.0%. This future growth will be driven by innovations in multi-omics technologies, a widening embrace of personalized medicine, rising investments in pharmaceutical research and development, heightened demand for predictive treatment outcomes, and the increasing integration of biomarkers into routine clinical care. Prominent trends anticipated during this period include growth in precision oncology applications, wider use of biomarkers for drug response stratification, more biomarker-guided clinical trial designs, greater adoption of companion diagnostics, and efforts to standardize biomarker validation processes.
Understanding Predictive Biomarkers and Their Role in Healthcare
Predictive biomarkers are biological indicators that provide valuable information about a person’s likelihood of developing certain diseases or responding to particular treatments. These markers can be genetic, proteomic, or molecular in nature, offering critical insights into disease susceptibility and treatment effectiveness. By tailoring therapies to an individual’s unique biomarker profile, healthcare providers can enhance treatment success rates and minimize adverse effects by identifying patients most likely to benefit from specific interventions.
View the full predictive biomarkers market report:
https://www.thebusinessresearchcompany.com/report/predictive-biomarkers-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR
Cancer as a Primary Driver of Market Expansion
One of the key factors propelling growth in the predictive biomarkers market is the rising incidence of cancer worldwide. Cancer involves uncontrolled cell growth that can invade nearby tissues and spread throughout the body. This increase in cancer cases is largely due to aging populations, lifestyle modifications, and greater exposure to risk factors such as tobacco use, poor dietary habits, and environmental pollution. Predictive biomarkers play a crucial role in cancer care by helping to pinpoint patients who are most likely to respond positively to targeted treatments, thereby enabling more personalized and effective therapies.
For example, in April 2024, the International Agency for Research on Cancer (IARC)—a specialized cancer research agency under the World Health Organization based in France—reported nearly 20 million new cancer cases and about 10 million cancer-related deaths in 2022. Projections indicate that by 2050, new cancer cases could soar to 35 million annually, marking a 77% increase from 2022 figures. Such data highlight the urgent need for predictive biomarkers in oncology, which in turn supports robust market growth.
Regional Overview of the Predictive Biomarkers Market
In 2025, North America held the largest share of the predictive biomarkers market. However, Europe is anticipated to be the fastest-growing region during the forecast period. The market report covers a wide range of geographic areas including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive global perspective on market dynamics and growth opportunities.
Our 2026 market reports now feature expanded strategic intelligence through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, key technology and future trend analysis, along with updated graphics and tables.
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company – www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company“
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
